Leukine (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Leukine drug offered from sanofi-aventis U.S. LLC. This Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | SARGRAMOSTIM |
| SUBSTANCE NAME: | SARGRAMOSTIM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1991-05-01 |
| END MARKETING DATE: | 0000-00-00 |
Leukine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Leukine from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(ug/mL) |
| START MARKETING DATE: | 1991-05-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5843_aca63889-1042-411c-8cc1-f4d5c0ee4f44 |
| PRODUCT NDC: | 0024-5843 |
| APPLICATION NUMBER: | BLA103362 |
Other SARGRAMOSTIM Pharmaceutical Manufacturers / Labelers:
